119 related articles for article (PubMed ID: 16787368)
1. Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the caco-2 cell monolayer system.
Wu S; Campbell C; Koda Y; Blanchfield JT; Toth I
Med Chem; 2006 Mar; 2(2):203-11. PubMed ID: 16787368
[TBL] [Abstract][Full Text] [Related]
2. Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues.
Wong AK; Ross BP; Chan YN; Artursson P; Lazorova L; Jones A; Toth I
Eur J Pharm Sci; 2002 Aug; 16(3):113-8. PubMed ID: 12128164
[TBL] [Abstract][Full Text] [Related]
3. Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells.
Balimane PV; Chong S; Patel K; Quan Y; Timoszyk J; Han YH; Wang B; Vig B; Faria TN
Arch Pharm Res; 2007 Apr; 30(4):507-18. PubMed ID: 17489369
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery.
Cros CD; Toth I; Blanchfield JT
Bioorg Med Chem; 2011 Feb; 19(4):1528-34. PubMed ID: 21273080
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
6. Transport characteristics of peptides and peptidomimetics: I. N-methylated peptides as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa.
Gao J; Sudoh M; Aubé J; Borchardt RT
J Pept Res; 2001 Apr; 57(4):316-29. PubMed ID: 11328489
[TBL] [Abstract][Full Text] [Related]
7. New and better protocols for a short-term Caco-2 cell culture system.
Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y
J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
9. Studies on intestinal absorption of sulpiride (1): carrier-mediated uptake of sulpiride in the human intestinal cell line Caco-2.
Watanabe K; Sawano T; Terada K; Endo T; Sakata M; Sato J
Biol Pharm Bull; 2002 Jul; 25(7):885-90. PubMed ID: 12132663
[TBL] [Abstract][Full Text] [Related]
10. Transport kinetics of leucine enkephalin across Caco-2 monolayers: quantitative analysis for contribution of enzymatic and transport barrier.
Quan YS; Fujita T; Tohara D; Tsuji M; Kohyama M; Yamamoto A
Life Sci; 1999; 64(14):1243-52. PubMed ID: 10210267
[TBL] [Abstract][Full Text] [Related]
11. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
Elsby R; Surry DD; Smith VN; Gray AJ
Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism.
Thomsen AE; Friedrichsen GM; Sørensen AH; Andersen R; Nielsen CU; Brodin B; Begtrup M; Frokjaer S; Steffansen B
J Control Release; 2003 Jan; 86(2-3):279-92. PubMed ID: 12526824
[TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
[TBL] [Abstract][Full Text] [Related]
14. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
Nielsen CU; Andersen R; Brodin B; Frokjaer S; Taub ME; Steffansen B
J Control Release; 2001 Sep; 76(1-2):129-38. PubMed ID: 11532319
[TBL] [Abstract][Full Text] [Related]
15. Reversible lipidization for the oral delivery of leu-enkephalin.
Wang J; Hogenkamp DJ; Tran M; Li WY; Yoshimura RF; Johnstone TB; Shen WC; Gee KW
J Drug Target; 2006 Apr; 14(3):127-36. PubMed ID: 16753826
[TBL] [Abstract][Full Text] [Related]
16. Application of enzymatically stable dipeptides for enhancement of intestinal permeability. Synthesis and in vitro evaluation of dipeptide-coupled compounds.
Friedrichsen GM; Jakobsen P; Taub M; Begtrup M
Bioorg Med Chem; 2001 Oct; 9(10):2625-32. PubMed ID: 11557350
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
Wu X; Whitfield LR; Stewart BH
Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
[TBL] [Abstract][Full Text] [Related]
18. An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes.
Tavelin S; Taipalensuu J; Hallböök F; Vellonen KS; Moore V; Artursson P
Pharm Res; 2003 Mar; 20(3):373-81. PubMed ID: 12669956
[TBL] [Abstract][Full Text] [Related]
19. Beta- and gamma-di- and tripeptides as potential substrates for the oligopeptide transporter hPepT1.
Hubatsch I; Arvidsson PI; Seebach D; Luthman K; Artursson P
J Med Chem; 2007 Oct; 50(21):5238-42. PubMed ID: 17887660
[TBL] [Abstract][Full Text] [Related]
20. Oral absorption enhancement of dipeptide L-Glu-L-Trp-OH by lipid and glycosyl conjugation.
Bergeon JA; Chan YN; Charles BG; Toth I
Biopolymers; 2008; 90(5):633-43. PubMed ID: 18428206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
